Edwards Lifesciences Corp. (EW) reported fourth quarter EPS of $0.84 after the bell Thursday, which fell short of the consensus estimate of $0.85. The company expects to report first quarter EPS of $0.77 to $0.81 and full year 2010 EPS of $3.50 to $3.60. The consensus estimates are for EPS of $0.82 and $3.56. The stock is now down 2.36 on 29K shares.
Edwards Lifesciences fell in the first hour of trade Thursday and declined for the majority of the afternoon. Shares finished down by 2.78 at $89.66 on above average volume.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.